Non-antimicrobial therapy of community-acquired pneumonia

Abstract

This publication deals with the issue of adjuvant (non-antimicrobial) therapy for community-acquired pneumonia. A critical analysis is provided on the appropriateness of using various drugs (mucolytics, non-steroidal anti-infl ammatory drugs, immunoglobulins, etc.) and physical methods of chest impact for community-acquired pneumonia, and recommendations are given for their clinical use. Special attention is paid to the use of systemic glucocorticosteroids and inhaled nitric oxide.